Medigene AG (MDG1) — Working Capital to Net Assets Ratio
Medigene AG (MDG1) has a Working Capital to Net Assets ratio of 46.3% as of June 2024. Working capital of €9.10 Million (current assets of €15.63 Million minus current liabilities of €6.53 Million) is measured against net assets of €19.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MDG1 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medigene AG Working Capital to Net Assets (2006–2023)
This chart shows how Medigene AG's Working Capital to Net Assets ratio has evolved across 18 annual periods from 2006 to 2023. As of June 2024, the ratio stands at 46.3%, reflecting working capital of €9.10 Million against net assets of €19.66 Million EUR. Check how tangible is Medigene AG's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Medigene AG (2006–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medigene AG from 2006 to 2023, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Medigene AG (MDG1) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 52.0% | €10.96 Million | €21.07 Million | €18.14 Million | €7.18 Million | ▼ -28.6 pp |
| 2022 | 80.6% | €29.84 Million | €37.03 Million | €37.25 Million | €7.42 Million | ▲ +44.6 pp |
| 2021 | 36.0% | €16.13 Million | €44.82 Million | €24.16 Million | €8.03 Million | ▼ -6.5 pp |
| 2020 | 42.5% | €22.56 Million | €53.15 Million | €32.70 Million | €10.13 Million | ▼ -15.6 pp |
| 2019 | 58.1% | €47.51 Million | €81.82 Million | €57.73 Million | €10.22 Million | ▲ +8.4 pp |
| 2018 | 49.7% | €53.38 Million | €107.42 Million | €62.20 Million | €8.82 Million | ▼ -12.4 pp |
| 2017 | 62.1% | €53.53 Million | €86.17 Million | €63.34 Million | €9.81 Million | ▼ -4.0 pp |
| 2016 | 66.2% | €52.01 Million | €78.59 Million | €63.97 Million | €11.97 Million | ▲ +10.3 pp |
| 2015 | 55.8% | €50.24 Million | €89.99 Million | €59.90 Million | €9.66 Million | ▲ +21.4 pp |
| 2014 | 34.5% | €16.91 Million | €49.07 Million | €24.67 Million | €7.75 Million | ▲ +3.7 pp |
| 2013 | 30.8% | €11.17 Million | €36.28 Million | €16.26 Million | €5.09 Million | ▼ -14.7 pp |
| 2012 | 45.5% | €20.13 Million | €44.22 Million | €24.45 Million | €4.32 Million | ▲ +17.9 pp |
| 2011 | 27.7% | €13.26 Million | €47.93 Million | €18.08 Million | €4.82 Million | ▲ +25.8 pp |
| 2010 | 1.9% | €771.00K | €40.80 Million | €17.93 Million | €17.16 Million | ▼ -11.9 pp |
| 2009 | 13.8% | €7.16 Million | €51.87 Million | €20.77 Million | €13.61 Million | ▼ -18.1 pp |
| 2008 | 31.9% | €20.72 Million | €64.91 Million | €36.18 Million | €15.46 Million | ▼ -11.3 pp |
| 2007 | 43.2% | €44.57 Million | €103.09 Million | €52.82 Million | €8.25 Million | ▲ +2.0 pp |
| 2006 | 41.2% | €44.69 Million | €108.51 Million | €57.26 Million | €12.57 Million | — |